ASP Isotopes (NASDAQ:ASPI) Trading 7.6% Higher - What's Next?

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) shot up 7.6% during trading on Thursday . The stock traded as high as $7.49 and last traded at $7.38. 440,366 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 2,576,629 shares. The stock had previously closed at $6.86.

Analyst Ratings Changes

Separately, Canaccord Genuity Group raised their target price on shares of ASP Isotopes from $8.50 to $11.00 and gave the stock a "buy" rating in a research report on Wednesday, May 21st.

ASP Isotopes Price Performance

The stock has a market cap of $622.47 million, a PE ratio of -12.17 and a beta of 3.56. The business has a fifty day simple moving average of $7.10 and a two-hundred day simple moving average of $5.71. The company has a current ratio of 7.21, a quick ratio of 7.17 and a debt-to-equity ratio of 0.80.

Insider Activity at ASP Isotopes

In related news, COO Robert Ainscow sold 66,668 shares of the stock in a transaction dated Thursday, April 17th. The shares were sold at an average price of $5.62, for a total value of $374,674.16. Following the completion of the transaction, the chief operating officer now directly owns 1,419,992 shares in the company, valued at $7,980,355.04. This trade represents a 4.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Paul Elliot Mann sold 316,666 shares of the business's stock in a transaction dated Thursday, April 17th. The stock was sold at an average price of $5.62, for a total transaction of $1,779,662.92. Following the sale, the chief executive officer now directly owns 7,315,454 shares in the company, valued at $41,112,851.48. The trade was a 4.15% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 766,667 shares of company stock worth $4,358,502 over the last ninety days. 21.40% of the stock is owned by corporate insiders.

Institutional Trading of ASP Isotopes

A number of hedge funds have recently made changes to their positions in ASPI. Rhumbline Advisers increased its position in ASP Isotopes by 8.2% during the 1st quarter. Rhumbline Advisers now owns 65,326 shares of the company's stock valued at $306,000 after buying an additional 4,963 shares in the last quarter. Philadelphia Financial Management of San Francisco LLC grew its stake in shares of ASP Isotopes by 11.2% in the first quarter. Philadelphia Financial Management of San Francisco LLC now owns 3,508,062 shares of the company's stock worth $16,453,000 after acquiring an additional 354,517 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of ASP Isotopes by 9.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company's stock valued at $148,000 after acquiring an additional 2,709 shares in the last quarter. Bosun Asset Management LLC bought a new position in shares of ASP Isotopes during the first quarter valued at $103,000. Finally, AWM Investment Company Inc. raised its position in shares of ASP Isotopes by 6.2% in the 1st quarter. AWM Investment Company Inc. now owns 4,511,186 shares of the company's stock worth $21,157,000 after purchasing an additional 265,000 shares during the last quarter. 16.80% of the stock is owned by institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.